JPRN-UMIN000037797
Recruiting
Phase 4
Prevention of sarcopenia by biologic agents and JAK inhibitors in rheumatoid arthritis; PRESENT study - PRESENT study
Department of Orthopaedic surgery, Osaka City General Hospital0 sites200 target enrollmentStarted: August 30, 2019Last updated:
Overview
- Phase
- Phase 4
- Status
- Recruiting
- Sponsor
- Department of Orthopaedic surgery, Osaka City General Hospital
- Enrollment
- 200
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Complicated with sever complication patients 2\.Autoimmune disease patients effected inflammation except rheumatoid arthritis
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Investigation of improvement of sarcopenia by suppression of hyperammonemia with rifaximin.cirrhotic patientJPRN-UMIN000048778Iwate Medical University School of Medicine20
Recruiting
Not Applicable
An intervention study to prevent sarcopenia in hospitalized patientsType2 diabetesJPRN-jRCTs051190108Ikeda Kaori80
Recruiting
Not Applicable
Efficacy of exercse therapy for sarcopenia preventionin dialysis patientschronic kidney diseaseJPRN-UMIN000037460fukui saiseikai hospital50
Not yet recruiting
Not Applicable
Sarcopenia Intervention for Breast Cancer PatientsNeoplasmsKCT0008961Yonsei University72
Completed
Not Applicable
Intervention study on flail and sarcopenia of elderly diabetic patientsFrail and sarcopenia in diabetic patientsJPRN-UMIN000030945Seiwakai Muta Hospital60